EUDA Health Holdings Limited (EUDAW)
| Market Cap | 46.11M -66.4% |
| Revenue (ttm) | 6.82M +70.0% |
| Net Income | -2.77M |
| EPS | -1.48 |
| Shares Out | 1.89M |
| PE Ratio | n/a |
| Forward PE | 11.49 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 91 |
| Open | n/a |
| Previous Close | 0.0299 |
| Day's Range | n/a |
| 52-Week Range | 0.0101 - 0.3000 |
| Beta | 0.64 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Dec 19, 2023 |
About EUDAW
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore.
News
EUDA Health enters collaboration for integrated iPSC cell therapy program
EUDA Health (EUDA) provided additional details of the integrated cell therapy program to be pursued under its non-binding Memorandum of Understanding with GO POSB Organoids and Shenzhen Innovation Imm...
EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
SINGAPORE, July 30, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and service...
EUDA Health signs MoU with GO POSB Organoids, SIIT
EUDA Health (EUDA) Holdings announced that it has signed a Memorandum of Understanding with GO POSB Organoids Pte and Shenzhen Innovation Immunotechnology Co., Ltd. to establish a tri-party collaborat...
EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
SINGAPORE, July 28, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and service...
EUDA Health Holdings Ltd trading resumes
10:24 EDT EUDA Health (EUDA) Holdings Ltd trading resumes
EUDA Health Holdings Ltd trading halted, volatility trading pause
10:19 EDT EUDA Health (EUDA) Holdings Ltd trading halted, volatility trading pause
EUDA Health regains Nasdaq compliance
EUDA Health (EUDA) received a written notice from Listing Qualifications Department of The Nasdaq Stock Market on April 23 indicating that the company had failed to maintain a Minimum Market…
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
SINGAPORE, June 01, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore...
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
Singapore, June 01, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (“EUDA” and the “Company”), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and...
EUDA Health Holdings Ltd trading halted, volatility trading pause
09:34 EDT EUDA Health (EUDA) Holdings Ltd trading halted, volatility trading pause
EUDA Health Holdings Ltd trading resumes
09:44 EDT EUDA Health (EUDA) Holdings Ltd trading resumes
EUDA Health Holdings Ltd trading halted, volatility trading pause
09:52 EDT EUDA Health (EUDA) Holdings Ltd trading halted, volatility trading pause
EUDA Health Holdings Ltd trading resumes
10:02 EDT EUDA Health (EUDA) Holdings Ltd trading resumes
EUDA Highlights Shenzhen Inno's Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development
SINGAPORE, April 28, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapo...
EUDA Health Holdings Ltd trading halted, volatility trading pause
09:45 EDT EUDA Health (EUDA) Holdings Ltd trading halted, volatility trading pause
EUDA Health Holdings Ltd trading resumes
09:55 EDT EUDA Health (EUDA) Holdings Ltd trading resumes
EUDA Health receives listing noncompliance notice from Nasdaq
EUDA Health (EUDA) received a written notice from the Listing Qualifications Department of Nasdaq on April 23 indicating that the company had failed to maintain a Minimum Market Value of…
EUDA Health Holdings Ltd trading resumes
09:36 EDT EUDA Health (EUDA) Holdings Ltd trading resumes
EUDA Health Holdings Ltd trading halted, volatility trading pause
09:31 EDT EUDA Health (EUDA) Holdings Ltd trading halted, volatility trading pause
EUDA Health Holdings Ltd trading halted, news pending
19:50 EDT EUDA Health (EUDA) Holdings Ltd trading halted, news pending
EUDA Announces Reverse Stock Split of its Ordinary Shares
SINGAPORE, March 19, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Ma...
EUDA Health price target lowered to $2.75 from $6 at Greenridge
Greenridge analyst William Gregozeski lowered the firm’s price target on EUDA Health (EUDA) to $2.75 from $6 and keeps a Buy rating on the shares. The firm updated its model…
EUDA Health announces repurchase, cancellation of Streeterville warrant
EUDA Health (EUDA) has repurchased and cancelled in full the warrant previously issued to Streeterville Capital. As previously disclosed, the Company entered into a securities purchase agreement dated...
EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant
SINGAPORE, March 04, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Ma...
EUDA Health announces second amendment to Streeterville warrant agreement
EUDA Health (EUDA) entered into a second amendment to its previously disclosed warrant agreement with Streeterville Capital. Under the terms of the Second Warrant Amendment dated January 13, the Compa...